Skip Navigation

Livestream

Create free account

Regeneron sinks on latest cancer drug trial

In this video

REGN

Regeneron sinks on latest cancer drug trial

Evan David Seigerman, BMO, joins 'Fast Money' to talk Regeneron shares falling sharply on failed cancer drug trial.

04:35

Mon, May 18 20265:47 PM EDT

Investors should take some money off the table, says MAI Capital's Chris Grisanti

Investors should take some money off the table, says MAI Capital's Chris Grisanti

an hour ago

Honeywell Aerospace CEO on Q2 spinoff: The biggest unlock for us will be around capital allocation

Honeywell Aerospace CEO on Q2 spinoff: The biggest unlock for us will be around capital allocation

2 hours ago

Parabolic tech mania continues: Investors' next move

Parabolic tech mania continues: Investors' next move

3 hours ago

Medtronic CEO says their core business is 'growing well'

Medtronic CEO says their core business is 'growing well'

3 hours ago

SpaceX targets fixed $135 IPO roadshow price at $1.75 trillion valuation, source says

SpaceX targets fixed $135 IPO roadshow price at $1.75 trillion valuation, source says

4 hours ago

Investors should take some money off the table, says MAI Capital's Chris Grisanti

Investors should take some money off the table, says MAI Capital's Chris Grisanti

an hour ago

Honeywell Aerospace CEO on Q2 spinoff: The biggest unlock for us will be around capital allocation

Honeywell Aerospace CEO on Q2 spinoff: The biggest unlock for us will be around capital allocation

2 hours ago

Parabolic tech mania continues: Investors' next move

Parabolic tech mania continues: Investors' next move

3 hours ago

Medtronic CEO says their core business is 'growing well'

Medtronic CEO says their core business is 'growing well'

3 hours ago

SpaceX targets fixed $135 IPO roadshow price at $1.75 trillion valuation, source says

SpaceX targets fixed $135 IPO roadshow price at $1.75 trillion valuation, source says

4 hours ago